Mission Ready Provides Update on Unifire Acquisition
VANCOUVER, British Columbia, Nov. 09, 2018 (GLOBE NEWSWIRE) — Mission Ready Solutions Inc. (“Mission Ready” or the “Company”) (TSXV:MRS) wishes to provide a general update on the Company’s progress, including (i) the non-binding letter of intent to acquire (the “Acquisition”) Unifire, Inc.; (ii) the engagement letter (the “Engagement Letter”) with Bay Crest Partners, LLC (the “Agent”); (iii) the fee agreement (the “Fee Agreement”) with Celadon Financial Group, LLC (“Celadon”); and (iv) the Foreign Military Distribution Agreement (the “Distribution Agreement”) first announced on September 6, 2017, with subsequent related announcements provided on September 20, 2017, November 30, 2017, and December 29, 2017.
Canada House Clinics Partners with Peak Pharma Solutions
TORONTO, Nov. 08, 2018 (GLOBE NEWSWIRE) — Canada House Clinics, the clinic division of Canada House Wellness Group Inc (“Canada House” or the “Company”) (CSE: CHV), is pleased to announce it has entered into a strategic partnership with Peak Pharma Solutions, leveraging its new clinic branding and organizational changes to position itself for accelerated growth.
1933 Industries Announces that its New Cultivation Facility is Nearing Completion
1933 Industries Inc. (CSE:TGIF, FWB:1QF, OTC:VPGDF) (the “Company” or “1933 Industries”) a licensed cultivator and producer of cannabis flower and concentrates and manufacturer of hemp/CBD wellness products, is pleased to provide an update regarding its expansion projects in Las Vegas, Nevada.
Quebec Government Invests Up to $3 Million in Nuran
NuRAN Wireless Inc. (CSE:NUR,FWB:1RN,OTCMKTS:NRRWF), a leading supplier of mobile and broadband wireless infrastructure solutions is pleased to announce that it has secured a long term low interest loan facility of up to $3M CAD with the Quebec Government and its ‘Creativite Quebec’ program.
Nuvo Pharmaceuticals Announces 2018 Third Quarter Results
MISSISSAUGA, ON, Nov. 8, 2018 /PRNewswire/ – Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX: NRI) (OTCQX: NRIFF), a globally focused, healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, today announced its financial and operational results for the third quarter ended September 30, 2018. For further details on the results, please refer to Nuvo’s Management, Discussion and Analysis (MD&A) and Condensed Consolidated Interim Financial Statements which are available on the Company’s website (www.nuvopharmaceuticals.com). All figures are in Canadian dollars, unless otherwise noted.
Nutritional High Comments on Results of Midterm Elections
TORONTO, Nov. 08, 2018 (GLOBE NEWSWIRE) — Nutritional High International Inc. (“Nutritional High” or the “Company”) (CSE: EAT, OTCQB: SPLIF, FRANKFURT: 2NU) wishes to provide comments on the results of the Midterm Elections and key regulatory developments in the US.
Nutritional High Completes Sale and Leaseback of Equipment
TORONTO, Nov. 06, 2018 (GLOBE NEWSWIRE) — Nutritional High International Inc. (“Nutritional High” or the “Company”) (CSE: EAT, OTCQB: SPLIF, FRANKFURT: 2NU) is pleased to announce that it has completed a sale and leaseback financing of certain equipment located at its FLI NorCal facility, located in Sacramento, California, and has leased other equipment to be delivered in short order (altogether, the “Equipment”) for gross proceeds of $741,127 USD. The sale and leaseback financing was provided by the Veterans Capital Corp. and ASC Lease Income, LLC (collectively, the “Buyer”).
FSD Pharma Report on “Steady Stomach” CBD Combination
TORONTO, Nov. 6, 2018 /CNW/ – FSD Pharma Inc. (“FSD Pharma”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today that its strategic R&D partner, SciCann Therapeutics Inc. (“SciCann”) received a positive International Search Authority (ISA) report from the Patent Cooperation Treaty (PCT) for its SCN-001 cannabidiol (CBD) combination therapy, the basis of its “Steady Stomach” product.
Engagement Labs’ Releases TotalSocial
NEW BRUNSWICK, N.J. and MONTREAL, Nov. 5, 2018 /PRNewswire/ — Engagement Labs Inc. (TSX VENTURE: EL) (OTCQB: ELBSF) today announced a major development in its TotalSocial® platform with the release of Version 3.2 which enables marketers to predict movements in their brand equity metrics months in advance, taking advantage of the predictive power of consumer conversations on long term brand equity. This is a first-of-its-kind capability that quantifies the relationship of conversations, both offline and online, with long-term business results and provides strategic guidance on how to drive performance improvement.